EE355 Budget Impact Model of a New rFVIIa (Eptacog Beta), for the On-Demand Treatment of Spontaneous Bleeding Events and Surgical Bleedings Among Hemophilia Patients with Inhibitors: A Payer Perspective From UK
Abstract
Authors
MC Marie M Gauthier Darnis B Tehard